Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Autoimmune Disease Diagnostics Market Size By Disease Type (Systemic Autoimmune Disease {Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Psoriasis, Multiple Sclerosis}, Localized Autoimmune Disease {Inflammatory Bowel Disease, Type 1 Diabetes, Thyroid}), By Test Type (Antinuclear Antibody Tests, Autoantibody Tests, C-reactive Protein (CRP), Complete Blood Count (CBC), Urinalysis), By End-use (Hospitals, Diagnostics Centers), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Application Potential, Competitive Market Share & Forecast, 2022 - 2030
... Tests, Autoantibody Tests, C-reactive Protein (CRP), Complete Blood Count (CBC), Urinalysis), By End-use (Hospitals, Diagnostics Centers), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Application Potential, Competitive Market Share & Forecast, 2022 - 2030 The ... Read More
-
Global Blood Glucose Test Strips Market Size study, by Component (Blood Glucose Test strips) and Regional Forecasts 2022-2028
... anticipated to grow with a healthy growth rate of more than 7% over the forecast period 2022-2028. An instrument used to measure blood glucose is known as a blood glucose test strip. It is a ... Read More
-
Chronic Disease Management Market By Type (Solutions, Services), By Disease Type (Cardiovascular diseases , Diabetes, Cancer, Asthma, Chronic obstructive pulmonary disorders, Others), By End User (Healthcare Providers, Healthcare Payers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Forecast, 2021-2031 The global chronic disease management market was valued at $4,896.69 million in 2021 and is projected to reach $14,875.48 million by 2031, registering a CAGR of 11.8% from 2022 to 2031. Chronic disease ... Read More
-
Condition Specific Report 2022
... at Cold/Flu/Immunity, we now see the impact that a two-plus year pandemic has on sales - a market $2.23 billion larger than 2019. A similar story continues with Mood and Mental Health and Sleep Support, ... Read More
-
Type 1 Diabetes - Pipeline Insight, 2022
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Insulin Pens -Market Insight, Competitive Landscape and Market Forecast, 2027
... User (Hospital And Retail Pharmacy, Clinics, And E-Commerece), by geography is expected to grow at a steady CAGR forecast till 2027 owing to increased prevalence of diabetes mellitus due to genetic factors, obesity, age, and ... Read More
-
United Kingdom Blood Glucose Monitoring Devices Market, By Product Type (Self Blood Glucose Monitoring Devices {Glucometers, Test Strips, Lancets} v/s Continuous Glucose Monitoring Devices {Sensors, Transmitters & Receivers, Integrated Insulin Pumps}), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Home Care Settings, Hospital, Others), By Region, Competition Forecast & Opportunities, 2027
... Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Home Care Settings, Hospital, Others), By Region, Competition Forecast & Opportunities, 2027 United Kingdom blood glucose monitoring devices market might register an impressive CAGR during the ... Read More
-
United Kingdom Renal Denervation Market, By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Micro-infusion), By Product (Catheters, Single Electrode Catheter, Multi Electrode Catheter, RF Generator, Others), By Therapeutic Area (Hypertension, Heart Failure, Diabetes, Renal Failure, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition Forecast & Opportunities, 2027
... Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition Forecast & Opportunities, 2027 United Kingdom renal denervation market may flourish with an impressive CAGR during the forecast period of 2023-2027, ... Read More
-
Diabetic Wounds- Market Insights, Competitive Landscape and Market Forecast–2027
... Care Devices [Negative Pressure Wound Therapy Devices, Hyperbaric & Oxygen Therapy Devices, Debridement Devices, Others], Skin Grafts & Substitutes, Growth Factors, Others), By Wound Type (Neuropathic Ulcer Wounds, Ischemic Ulcer Wounds, Neuro-Ischemic Ulcer Wounds), By ... Read More
-
Insulin Delivery Device- Market Insights, Competitive Landscape and Market Forecast–2027
... (Homecare Settings, Diabetes Centers, Hospitals, and Others), By Geography is anticipated to expand at a significant CAGR forecast till 2027 due to rising prevalence of diabetes across the globe and rising awareness regarding proper diabetes ... Read More
-
Smart Insulin Pens - Market Insights, Competitive Landscape and Market Forecast-2027
... others), by geography is expected to grow at a steady cagr forecast till 2027 owing to increased prevalence of diabetes mellitus due to genetic factors, obesity, age, and unhealthy lifestyles and enchanced awarness of self-management ... Read More
-
Europe Digital Therapeutics Market by Application (Diabetes, Obesity, CVD, CNS Disease Respiratory Diseases, Smoking Cessation and Others); By End Use (Patients, Providers, Payers, Employers and Others); By Type (Software and Devices), and Region – Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030
... of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030 Europe Digital Therapeutics Market is anticipated to surpass USD 4 billion by 2030 from USD 0.5 billion in 2020 at a ... Read More
-
Chronic Pain associated with Painful Diabetic Neuropathy- Market Insight, Competitive Landscape and Market Forecast, 2027
... in-depth understanding of Chronic Pain associated with Painful Diabetic Neuropathy and the historical and forecasted Chronic Pain associated with Painful Diabetic Neuropathy market trends, globally, which comprises of North America, Europe, APAC, and RoW. The ... Read More
-
Artificial Pancreas Device System- Market Insights, Competitive Landscape and Market Forecast–2027
... and the historical and forecasted Artificial Pancreas Device System market trends, globally, which comprises of North America, Europe, APAC, and RoW. The Artificial Pancreas Device System market report provides an overview of Artificial Pancreas Device ... Read More
-
Complementary and Alternative Medicine Market By Type (Medicines, Therapy), By Disease Indication (Diabetes, Cardiovascular, Neurology, Cancer, Arthritis, Others), By Distribution Channels (Direct Sales, Online Sales, Distance Correspondence): Global Opportunity Analysis and Industry Forecast, 2021-2031
... global complementary and alternative medicine market was valued at $101,995.95 million in 2021 and is projected to reach $437,864.92 million by 2031, registering a CAGR of 15.6% from 2022 to 2031 The term complementary and ... Read More
-
Proliferative Diabetic Retinopathy (PDR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorders) pipeline landscape. Proliferative diabetic retinopathy (PDR) is the most severe type of diabetic retinopathy. Proliferative diabetic retinopathy occurs where fragile ... Read More
-
Diabetic Footwear Market, by Product Type (Sandals, Shoes, and Slippers), by Distribution Channel (Online Stores, Supermarkets, Hypermarkets, Specialty Stores, and Others), by End User (Male, Female, and Kids) and by Region (North America, Latin America, Asia Pacific, Europe, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Asia Pacific, Europe, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Diabetes is a disorder caused due to the lack or low levels of insulin in the body. ... Read More
-
In-vitro Diagnostics Market Size By Product Type (Reagents & Kits, Instruments), By Test Type (Clinical Chemistry, Immunoassay/Immunochemistry, Molecular Diagnostics, Hematology, Urinalysis), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/Pharmacogenomics), By End-user (Hospitals, Diagnostic Laboratories, Academic & Research Institutes), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
... (Hospitals, Diagnostic Laboratories, Academic & Research Institutes), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030 The in-vitro diagnostics market is expected to grow massively by 2030 on account ... Read More
-
Biopharmaceutical and Biomedicine Market, by Product Type (Biopharmaceutical (Monoclonal Antibodies, Vaccines, Recombinant Human Insulin, Human Growth Hormone, Erythropoietin, Interferon, Colony Stimulating Factor, Blood Factors, Fusion Protein, and Others), Nanomedicine, Cell & Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Canada Insulin Delivery Devices Market, By Insulin Delivery Devices ((Insulin Pump (Insulin Pump Device, Insulin Infusion Sets, and Insulin Reservoirs), Insulin Syringes, Insulin Disposable Pens, Insulin Cartridges in Reusable Pens, and Insulin Jet Injectors)) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Insulin, a glucose directing hormone, is an essential part of the treatment plan for people with type 1 diabetes mellitus and advanced type 2 diabetes mellitus. ... Read More
-
Biosimilars Market Size By Product (Recombinant Non-Glycosylated Proteins {Human Growth Hormone, Granulocyte Colony-Stimulating Factor, Insulin, Interferon}, Recombinant Glycosylated Proteins {Erythropoietin, Monoclonal Antibodies, Follitropin, Low Molecular Weight Heparin}), By Application (Hematology {Neutropenia, Anemia}, Oncology {Lung Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Leukemia or Blood Cancer}, Autoimmune Disease {Arthritis, Inflammatory Bowel Disease, Psoriasis}, Growth Hormone Deficiency, Diabetes), By Manufacturer (Contract Research and Manufacturing Services, In-house), By Technology (Recombinant DNA Technology, Monoclonal Antibodies Technology) Industry Analysis Report, Regional Outlook, Application Potential, COVID-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2030
... Brain Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Leukemia or Blood Cancer}, Autoimmune Disease {Arthritis, Inflammatory Bowel Disease, Psoriasis}, Growth Hormone Deficiency, Diabetes), By Manufacturer (Contract Research and Manufacturing Services, In-house), By Technology (Recombinant DNA ... Read More
-
Global Pediatric Clinical Trials Market Size study, By Phase (Phase I, Phase II, Phase III, and Phase IV), By Study Design (Treatment Studies and Observational Studies), By Therapeutic Area (Respiratory Diseases, Infectious Diseases, Oncology, Diabetes and Other Therapeutic Areas), and Regional Forecasts 2022-2028
... and Other Therapeutic Areas), and Regional Forecasts 2022-2028 Global Pediatric Clinical Trials Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX ... Read More
-
Global Missouri Medical Cannabis Market Size study, By Product Type (Flower, Oils & Tinctures), By Application (Cancer, Chronic Pain, Arthritis, Diabetes, AIDS, Others), and Regional Forecasts 2022-2028
... USDXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Missouri medical cannabis is also known as marijuana, which is any strain ... Read More
-
Asia Pacific Wound Care Biologics Market, By Product Type (Biologic Skin Substitutes, Enzyme Based Formulations, and Growth Factors), By Application (Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, and Pressure Ulcers) and Acute Wounds(Surgical Wounds, Burns)), By End User (Hospital (In-patient Settings and Out-patient Settings), Clinics, Ambulatory Surgical Centers, and Home Care Settings), and By Country (China, India, Japan, Australia, South Korea, ASEAN, and Rest of APAC) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Burns)), By End User (Hospital (In-patient Settings and Out-patient Settings), Clinics, Ambulatory Surgical Centers, and Home Care Settings), and By Country (China, India, Japan, Australia, South Korea, ASEAN, and Rest of APAC) - Size, Share, ... Read More
-
Wound Care Biologics Market by Product (Biological Skin Substitutes, Topical Agents), Wound Type (Ulcers [Diabetic Foot, Venous, Pressure Ulcers], Surgical & Traumatic Wounds, Burns), End User (Hospitals, ASCs, Burn Centers) – Global Forecast to 2027
... The global wound care biologics market is valued at an estimated USD 1.8billion in 2022 and is projected to reach USD 2.4billion by 2027, at a CAGR of 5.4% during the forecast period. Market growth ... Read More
Research Assistance
